Package 0299-6220-10

{"route": ["SUBCUTANEOUS"], "spl_id": "df0e2be2-b6bd-40e5-9175-0c8e893433ea", "openfda": {"nui": ["N0000194121", "N0000194122"], "unii": ["GN465U8B72"], "rxcui": ["2691325", "2691328"], "spl_set_id": ["e9229ef1-ac60-4c24-afb6-009d3c781687"], "pharm_class_epc": ["Interleukin-31 Receptor alpha Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-31 Receptor alpha Antagonists [MoA]"], "manufacturer_name": ["Galderma Laboratories, L.P."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 SYRINGE, GLASS in 1 CARTON (0299-6220-10)  / 30 mg in 1 SYRINGE, GLASS", "package_ndc": "0299-6220-10", "marketing_start_date": "20240813"}, {"sample": false, "description": "1 SYRINGE in 1 CARTON (0299-6220-15)  / 30 mg in 1 SYRINGE", "package_ndc": "0299-6220-15", "marketing_start_date": "20240813"}], "brand_name": "NEMLUVIO", "product_id": "0299-6220_df0e2be2-b6bd-40e5-9175-0c8e893433ea", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Interleukin-31 Receptor alpha Antagonist [EPC]", "Interleukin-31 Receptor alpha Antagonists [MoA]"], "product_ndc": "0299-6220", "generic_name": "nemolizumab-ilto", "labeler_name": "Galderma Laboratories, L.P.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NEMLUVIO", "active_ingredients": [{"name": "NEMOLIZUMAB", "strength": "30 mg/100mg"}], "application_number": "BLA761390", "marketing_category": "BLA", "marketing_start_date": "20240813", "listing_expiration_date": "20261231"}